Veronique Lecault
CIK: 0001834418
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABCL
AbCellera Biologics Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Lecault Veronique
Lecault Veronique (SEC CIK 0001834418) files insider reports with the SEC as Chief Technology Officer of AbCellera Biologics Inc. (ABCL).
Signal8 holds 2 ownership filings by Lecault Veronique, all Form 4s, filed between Jan 3, 2025 and Jan 5, 2026. Those filings report 2 transactions, from Jan 1, 2025 to Jan 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lecault Veronique's filings is in VANCOUVER, A1.
Recent filings by Lecault Veronique
Other insiders filing for AbCellera Biologics Inc. (ABCL)
- Hayden Michael R, Director
- Montalbano John S., Director
- Booth Andrew, Chief Financial Officer
- Seely Lynn, Director
- Sandor Victor, Director
- Quake Stephen, Director